Dual-targeting biomimetic liposome with elemene (ele) and cabazitaxel (ctx), and preparation method and use thereof
US-2024252436-A1 · Aug 1, 2024 · US
US8940684B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940684-B2 |
| Application number | US-201313815775-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2013 |
| Priority date | Nov 19, 2012 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure describes collagen constructs comprising antifungal agents, preferably, copper, and related methods.
Opening claim text (preview).
The invention claimed is: 1. An antifungal cross-linked collagen construct comprising: a cross-linked collagen comprising collagen and one or more cross-linking agents and an antifungal amount of copper incorporated into the construct, wherein at least a portion of the copper is chelated to one or more of the cross-linking agents, and at least another portion of the copper is bound to the construct via one or more of covalent, non-covalent, ionic, and metallic bonds.…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.